åêðáéäåõóçó γ.ν.α.
åêðáéäåõóçó γ.ν.α.
åêðáéäåõóçó γ.ν.α.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ΝΟΣΟΚΟΜΕΙΑΚΑ ΧΡΟΝΙΚΑ, ΤΟΜΟΣ 71, ΣΥΜΠΛΗΡΩΜΑ, 2009<br />
487<br />
of transforming growth factor B is elevated in human<br />
and experimental diabetic nephropathy. Proc. Nat. Acad.<br />
Sci. USA 1993: 90, 1814 – 1818<br />
6. Nagasaka Y, EujiiS, Kaneco T: Effects of high glucose<br />
and sorbitol path way on lipid peroxidation. Horm. Met.<br />
Res. 1989: 21: 275 – 276<br />
7. Brownlee M,: Glycation and Diabetic complication.<br />
Diabetes, 1994, 43: 813 – 835<br />
8. DCCT: The effect of intensive treatment of diabetes<br />
on the development and progression of long-term<br />
complications in insulin-dependent diabetes mellitus.<br />
The Diabetes Control and Complications Trial Research<br />
Group. N Engl J Med: 1993, 329:977–986<br />
9. UKPDS: Intensive blood-glucose control with sulphonylureas<br />
or insulin compared with conventional treatment<br />
and risk of complications in patients with type 2<br />
diabetes (UKPDS 33). UK Prospective Diabetes Study<br />
(UKPDS) Group. Lancet 1998: 352:837–853<br />
10. UKPDS: Effect of intensive blood-glucose control with<br />
metformin on complications in overweight patients with<br />
type 2 diabetes (UKPDS 34). UK Prospective Diabetes<br />
Study (UKPDS) Group. Lancet: 1998 352:854–865<br />
11. DCCT-EDIC: Retinopathy and nephropathy in patients<br />
with type 1 diabetes four years after a trial of intensive<br />
therapy. The Diabetes Control and Complications<br />
Trial/Epidemiology of Diabetes Interventions and<br />
Complications Research Group. N Engl J Med 2000:<br />
342:381–389<br />
12. Holman R, Sanjoy K, Bethel A. et al: 10 Year Follow<br />
- up of Intensive Glucose Control in Type 2 Diabetes.<br />
N Engl J Med 2008; 1577–89<br />
13. Melmberg K, Ryden L, Efendic S et al.; Randomized trial<br />
of insulin – glucose infusion followed by subcutaneous<br />
insulin treatment in diabetec patients with acute myocardial<br />
infraction (DIGAMI) study effect on mortality at<br />
1 year. J Am Coll. Cardiol. 1995;26: 57 – 65<br />
14. American Diabetes Assiciation: Standards of medical care<br />
in diabetes. Diabetes Care 2008; 28(supl) s4 – s56<br />
15. Gaede P, Veedel P, Larsen N, et al. Multifactorial intervention<br />
and cardiovascular disease in patients with<br />
type 2 diabetes. N.EJM 2003:348: 383 – 393<br />
16. The Action to Control Cardiovascular Risk in Diabetes<br />
Study Group. Effects of intensive glucose lowering in<br />
type 2 diabetes. N Engl J Med 2008;358:2545-2559<br />
17. Cefallu W: Glycemic Targets and Cardiovascular Disease.<br />
N Engl J Med 2008;358:2633-2635<br />
18. The ADVANCE Collaborative Group. Intensive blood<br />
glucose control and vascular outcomes in patients with<br />
type 2 diabetes. N Engl J Med 2008;358:2560-2572<br />
19. Medscape: CORRECTION: VA Diabetes Trial Shows<br />
That Intesive Glucose Has Little Effect on Cardiovascular<br />
Risk June 2008<br />
xxxxxxxxxxx<br />
xxxxxx
Change language